Additionally, to confirm whether KIFC2 promoted the PCa progression and Enza resistance by NF-κB p65, we pretreated KIFC2-overexpressing PCa cells with NF-κB chemical inhibitors GSK583. The gene discussed is KIFC2; the disease is posterior cortical atrophy.